Literature DB >> 15564495

Determinants of high titer in recombinant porcine endogenous retroviruses.

Ian Harrison1, Yasuhiro Takeuchi, Birke Bartosch, Jonathan P Stoye.   

Abstract

Porcine endogenous retroviruses (PERVs) pose a potential stumbling block for therapeutic xenotransplantation, with the greatest threat coming from viruses generated by recombination between members of the PERV subgroup A (PERV-A) and PERV-C families (PERV-A/C recombinants). PERV-A and PERV-B have been shown to infect human cells in culture, albeit with low titers. PERV-C has a more restricted host range and cannot infect human cells. A recombinant PERV-A/C virus (PERV-A14/220) contains the PERV-A sequence between the end of pol and the middle of the SU region in env. The remaining sequence is derived from PERV-C. PERV-A14/220 is approximately 500-fold more infectious than PERV-A. To determine the molecular basis for the increased infectivity of PERV-A14/220, we have made a series of vector constructs. The primary determinant for the enhanced replicative potential of the recombinant virus appeared to be the env gene. Using a series of chimeric env genes, we could identify two determinants of high infectivity; one was an isoleucine to valine substitution at position 140 between variable regions A and B, and the other lies within the proline rich region. Taken together, these results show that the novel juxtaposition of env gene sequences enhanced the infectivity of PERV-A14/220 for human cells, perhaps by stabilization of the envelope glycoprotein or increased receptor binding.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564495      PMCID: PMC533952          DOI: 10.1128/JVI.78.24.13871-13879.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

Review 1.  Infection hazards of xenotransplantation.

Authors:  R A Weiss; S Magre; Y Takeuchi
Journal:  J Infect       Date:  2000-01       Impact factor: 6.072

2.  Use of a transient assay for studying the genetic determinants of Fv1 restriction.

Authors:  M Bock; K N Bishop; G Towers; J P Stoye
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  Extended analysis of the in vitro tropism of porcine endogenous retrovirus.

Authors:  C A Wilson; S Wong; M VanBrocklin; M J Federspiel
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes.

Authors:  D Lavillette; M Maurice; C Roche; S J Russell; M Sitbon; F L Cosset
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

5.  Murine leukemia virus-based Tat-inducible long terminal repeat replacement vectors: a new system for anti-human immunodeficiency virus gene therapy.

Authors:  P M Cannon; N Kim; S M Kingsman; A J Kingsman
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  Infection of human cells by an endogenous retrovirus of pigs.

Authors:  C Patience; Y Takeuchi; R A Weiss
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

7.  Identification of novel porcine endogenous betaretrovirus sequences in miniature swine.

Authors:  T Ericsson; B Oldmixon; J Blomberg; M Rosa; C Patience; G Andersson
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells.

Authors:  C A Wilson; S Wong; J Muller; C E Davidson; T M Rose; P Burd
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

9.  Characterization of the proline-rich region of murine leukemia virus envelope protein.

Authors:  B Weimin Wu; P M Cannon; E M Gordon; F L Hall; W F Anderson
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Host range and interference studies of three classes of pig endogenous retrovirus.

Authors:  Y Takeuchi; C Patience; S Magre; R A Weiss; P T Banerjee; P Le Tissier; J P Stoye
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more
  35 in total

1.  Comparison of the convergent receptor utilization of a retargeted feline leukemia virus envelope with a naturally-occurring porcine endogenous retrovirus A.

Authors:  Peter M Mazari; Takele Argaw; Leonardo Valdivieso; Xia Zhang; Katherine T Marcucci; Daniel R Salomon; Carolyn A Wilson; Monica J Roth
Journal:  Virology       Date:  2012-03-08       Impact factor: 3.616

2.  Retroviral restriction factors and infectious risk in xenotransplantation.

Authors:  Y Meije; R R Tönjes; J A Fishman
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

Review 3.  The origin of porcine endogenous retroviruses (PERVs).

Authors:  Joachim Denner
Journal:  Arch Virol       Date:  2021-02-06       Impact factor: 2.574

4.  Screening pigs for xenotransplantation: expression of porcine endogenous retroviruses in transgenic pig skin.

Authors:  Magdalena Kimsa-Dudek; Barbara Strzalka-Mrozik; Malgorzata W Kimsa; Irena Blecharz; Joanna Gola; Bartlomiej Skowronek; Adrian Janiszewski; Daniel Lipinski; Joanna Zeyland; Marlena Szalata; Ryszard Slomski; Urszula Mazurek
Journal:  Transgenic Res       Date:  2015-03-27       Impact factor: 2.788

5.  Evidence and consequence of porcine endogenous retrovirus recombination.

Authors:  Birke Bartosch; Dimitrios Stefanidis; Richard Myers; Robin Weiss; Clive Patience; Yasuhiro Takeuchi
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  Mice transgenic for a human porcine endogenous retrovirus receptor are susceptible to productive viral infection.

Authors:  Y Martina; K T Marcucci; S Cherqui; A Szabo; T Drysdale; U Srinivisan; C A Wilson; C Patience; D R Salomon
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  Functional hierarchy of two L domains in porcine endogenous retrovirus (PERV) that influence release and infectivity.

Authors:  Katherine T Marcucci; Yuri Martina; Frank Harrison; Carolyn A Wilson; Daniel R Salomon
Journal:  Virology       Date:  2008-03-19       Impact factor: 3.616

8.  Identification of residues outside of the receptor binding domain that influence the infectivity and tropism of porcine endogenous retrovirus.

Authors:  Takele Argaw; Mariel Figueroa; Daniel R Salomon; Carolyn A Wilson
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

9.  Susceptibility of porcine endogenous retrovirus to anti-retroviral inhibitors.

Authors:  Takele Argaw; Winston Colon-Moran; Carolyn Wilson
Journal:  Xenotransplantation       Date:  2016-03-29       Impact factor: 3.907

10.  Genome areas with high gene density and CpG island neighborhood strongly attract porcine endogenous retrovirus for integration and favor the formation of hot spots.

Authors:  Y Moalic; H Félix; Y Takeuchi; A Jestin; Y Blanchard
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.